Related Experiment Video
Updated: Mar 31, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.0K
Comorbidities in Psoriatic Arthritis.
1Department of Rheumatic and Immunologic Diseases, Clinical Outcomes Research, Arthritis and Musculoskeletal Center, Cleveland Clinic, Desk A50, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Rheumatic Diseases Clinics of North America
|October 18, 2015
Summary
Psoriatic arthritis (PsA) patients frequently experience comorbidities like cardiovascular disease and diabetes. Recognizing these associated conditions is crucial for effective PsA management and improved patient outcomes.
Area of Science:
- Rheumatology and Immunology
- Internal Medicine
- Public Health
Background:
- Psoriatic arthritis (PsA) is increasingly recognized as a systemic inflammatory disease.
- Epidemiologic data suggest a higher prevalence of comorbidities in PsA patients than anticipated.
- These comorbidities can significantly impact disease course and patient prognosis.
Purpose of the Study:
- To review and discuss the common comorbidities associated with psoriatic arthritis.
- To highlight the importance of identifying these comorbidities for optimal clinical management.
- To inform healthcare providers about the impact of comorbidities on treatment decisions in PsA.
Main Methods:
- Review of existing epidemiologic studies and clinical literature on psoriatic arthritis comorbidities.
- Synthesis of information regarding the prevalence and types of associated conditions.
- Discussion of the clinical implications for patient care and management strategies.
Main Results:
- PsA is frequently associated with a range of comorbidities.
- Commonly identified comorbidities include cardiovascular disease, metabolic syndrome, obesity, diabetes, fatty liver disease, inflammatory bowel disease, ophthalmic disease, kidney disease, osteoporosis, depression, and anxiety.
- These conditions occur more often than expected in the PsA population.
Conclusions:
- Awareness of comorbidities is essential for healthcare providers managing PsA patients.
- Identification and management of associated conditions are critical for optimizing treatment outcomes.
- A comprehensive approach addressing both PsA and its comorbidities is necessary for holistic patient care.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
669
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
669
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.0K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K